Page last updated: 2024-08-26

wr 1065 and cp 31398

wr 1065 has been researched along with cp 31398 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bykov, VJ; Selivanova, G; Wiman, KG1
Omar, SI; Tuszynski, J1

Reviews

1 review(s) available for wr 1065 and cp 31398

ArticleYear
Small molecules that reactivate mutant p53.
    European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:13

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ellipticines; Gene Expression Regulation, Neoplastic; Genes, p53; Genetic Therapy; Humans; Mercaptoethylamines; Molecular Chaperones; Mutation; Neoplasms; Pyrimidines

2003

Other Studies

1 other study(ies) available for wr 1065 and cp 31398

ArticleYear
Ranking the Binding Energies of p53 Mutant Activators and Their ADMET Properties.
    Chemical biology & drug design, 2015, Volume: 86, Issue:2

    Topics: Alkylation; Amifostine; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Drug Evaluation, Preclinical; Ellipticines; Heterocyclic Compounds, 4 or More Rings; Humans; Kinetics; Ligands; Mercaptoethylamines; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Mutation; Oxepins; Protein Binding; Pyrimidines; Quinuclidines; Tumor Suppressor Protein p53

2015